Market Place
Sourcing Support
Janssen`s Biologic NIpocalimab Receives Approval in US
29 Apr 2025 //
FDA
Janseen`s Biologic Simponi Aria Receives Suppl Approval in US
18 Apr 2025 //
FDA
Janseen Biotech`s Biologic Stelara Receives Approval in US
01 Apr 2025 //
FDA
Janssen biotech`s Biologic Rybrevant Receives Suppl Approval in US
14 Feb 2025 //
FDA
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024
22 Jan 2025 //
GLOBENEWSWIRE
Janseen`s Biologic Tecvayli Receives Suppl Approval in US
22 Nov 2024 //
FDA
Genmab Announces Net Sales of Darzalex for Third Quarter of 2024
15 Oct 2024 //
GLOBENEWSWIRE
Janssen`s Biologic Rybrevant (Amivantamab) Receives Suppl Approval in US
19 Sep 2024 //
FDA
Janssen Biotech`s Biologic Tremfya (Guselkumab) Receives Approval in US
11 Sep 2024 //
FDA
BigHat Collaborates on Antibody Design with ML
24 Apr 2024 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.